Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management.
This review offers a detailed analysis of managing type 2 diabetes (T2D) in gastric cancer (GC) patients across the surg...
This review offers a detailed analysis of managing type 2 diabetes (T2D) in gastric cancer (GC) patients across the surg...
You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…
This scoping review evaluates digital health interventions (DHIs) aimed at increasing colorectal cancer (CRC) screening...
This study reports the development and validation of a non-invasive circulating cell-free DNA (cfDNA)-based model for ea...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis, primarily due to late diagnos...
The publication discusses recent advancements in targeted therapies for non-small cell lung cancer (NSCLC). It highlight...